WHO ICTRP trial

A Study of Autologous Adipose-Derived Stromal Vascular Fraction (SVF) for…

KCT0011317 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0011317
Public title A Study of Autologous Adipose-Derived Stromal Vascular Fraction (SVF) for Treatment of Knee Osteoarthritis
Scientific title A Single center, Double-blind, Randomized, Phase 4 Study to Evaluate the Efficacy and Safety of Autologous Adipose-Derived Stromal Vascular Fraction (SVF) in Knee Osteoarthritis
Primary sponsor Yonsei University Health System, Gangnam Severance Hospital
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Phase4
Countries Korea, Republic of
Conditions Diseases of the musculoskeletal system and connective tissue
Interventions Biological/Vaccine, Stem Cell : The intervention group received a single intra-articular injection of autologous adipose-derived stromal vascular fraction (SVF) extracted from adipose tissue. The control group received a placebo injection (…
Registration date Dec 12, 2025
Target size 45
Registry page cris.nih.go.kr

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations